1 |
Sheng H, Shao J, Williams CS, et al (1998). Nuclear translocation of beta-catenin in hereditary and carcinogen-induced intestinal adenomas. Carcinogenesis, 19, 543-9.
DOI
ScienceOn
|
2 |
Solinas G, Marchesi F, Garlanda C, et al (2010). Inflammationmediated promotion of invasion and metastasis. Cancer Metastasis Rev, 29, 243-8.
DOI
ScienceOn
|
3 |
Sparks AB, Morin PJ, Vogelstein B, et al (1998). Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer. Cancer Res, 58, 1130-4.
|
4 |
Steinman L (2007). A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med, 13, 139-45.
DOI
ScienceOn
|
5 |
Stolfi C, Rizzo A, Franze E, et al (2011). Involvement of interleukin-21 in the regulation of colitis-associated colon cancer. J Exp Med, 208, 2279-90.
DOI
ScienceOn
|
6 |
Suzui M, Ushijima T, Dashwood RH, et al (1999). Frequent mutations of the rat beta-catenin gene in colon cancers induced by methylazoxymethanol acetate plus 1-hydroxyanthraquinone. Mol Carcinog, 24, 232-7.
DOI
|
7 |
Suzuki A, Hanada T, Mitsuyama K, et al (2001). CIS3/SOCS3/SSI3 plays a negative regulatory role in STAT3 activation and intestinal inflammation. J Exp Med, 193, 471-81.
DOI
ScienceOn
|
8 |
Yu H, Pardoll D, Jove R (2009). STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer, 9, 798-809.
DOI
ScienceOn
|
9 |
Yang Y, Yan X, Duan W, et al (2013). Pterostilbene Exerts Antitumor Activity via the Notch1 Signaling Pathway in Human Lung Adenocarcinoma Cells. PLoS ONE, 8, 62652.
DOI
|
10 |
Yu H, Jove R (2004). The STATs of cancer--new molecular targets come of age. Nat Rev Cancer, 4, 97-105.
DOI
ScienceOn
|
11 |
Yu H, Kortylewski M, Pardoll D (2007). Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment. Nat Rev Immunol, 7, 41-51.
DOI
ScienceOn
|
12 |
Zhang HY, Spechler SJ, Souza RF (2009). Esophageal adenocarcinoma arising in Barrett esophagus. Cancer Lett, 275, 170-7.
DOI
ScienceOn
|
13 |
Zhong Z, Wen Z, Darnell JE, Jr (1994). Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science, 264, 95-8.
DOI
|
14 |
Thiem S, Pierce TP, Palmieri M, et al (2013). mTORC1 inhibition restricts inflammation-associated gastrointestinal tumorigenesis in mice. J Clin Invest, 123, 767-81.
|
15 |
Tian Y, Ye Y, Gao W, et al (2011). Aspirin promotes apoptosis in a murine model of colorectal cancer by mechanisms involving downregulation of IL-6-STAT3 signaling pathway. Int J Colorectal Dis, 26, 13-22.
DOI
|
16 |
Seidelin JB, Nielsen OH (2005). Continuous cytokine exposure of colonic epithelial cells induces DNA damage. Eur J Gastroenterol Hepatol, 17, 363-9.
DOI
|
17 |
Seo HS, Choi HS, Kim SR, et al (2012). Apigenin induces apoptosis via extrinsic pathway, inducing p53 and inhibiting STAT3 and NFkappaB signaling in HER2-overexpressing breast cancer cells. Mol Cell Biochem, 366, 319-34.
DOI
|
18 |
Van Kemseke C, Belaiche J, Louis E (2000). Frequently relapsing Crohn's disease is characterized by persistent elevation in interleukin-6 and soluble interleukin-2 receptor serum levels during remission. Int J Colorectal Dis, 15, 206-10.
DOI
|
19 |
Zhu H, Zhou X, Redfield S, et al (2013). Elevated Jagged-1 and Notch-1 expression in high grade and metastatic prostate cancers. Am J Transl Res, 5, 368-78.
|
20 |
Tyagi A, Singh RP, Ramasamy K, et al (2009). Growth inhibition and regression of lung tumors by silibinin: modulation of angiogenesis by macrophage-associated cytokines and nuclear factor-kappaB and signal transducers and activators of transcription 3. Cancer Prev Res, 2, 74-83.
DOI
ScienceOn
|
21 |
Ullman TA, Itzkowitz SH (2011). Intestinal inflammation and cancer. Gastroenterology, 140, 1807-16.
DOI
ScienceOn
|
22 |
Villanueva A, Alsinet C, Yanger K, et al (2012). Notch signaling is activated in human hepatocellular carcinoma and induces tumor formation in mice. Gastroenterology, 143, 1660-9.
DOI
ScienceOn
|
23 |
Wang B, Xiao Z, Chen B, et al (2008). Nogo-66 promotes the differentiation of neural progenitors into astroglial lineage cells through mTOR-STAT3 pathway. PLoS ONE, 3, 1856.
DOI
ScienceOn
|
24 |
Wang Z, Jin H, Xu R, et al (2009). Triptolide downregulates Rac1 and the JAK/STAT3 pathway and inhibits colitisrelated colon cancer progression. Exp Mol Med, 41, 717-27.
DOI
ScienceOn
|
25 |
Ward JM (1974). Morphogenesis of chemically induced neoplasms of the colon and small intestine in rats. Lab Invest, 30, 505-13.
|
26 |
Wodarz A, Nusse R (1998). Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Biol, 14, 59-88.
DOI
ScienceOn
|
27 |
Yan S, Zhou C, Zhang W, et al (2008). beta-Catenin/TCF pathway upregulates STAT3 expression in human esophageal squamous cell carcinoma. Cancer Lett, 271, 85-97.
DOI
ScienceOn
|
28 |
Zhou J, Wulfkuhle J, Zhang H, et al (2007). Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance. Proc Natl Acad Sci U S A, 104, 16158-63.
DOI
ScienceOn
|
29 |
Deng L, Zhou JF, Sellers RS, et al (2010). A novel mouse model of inflammatory bowel disease links mammalian target of rapamycin-dependent hyperproliferation of colonic epithelium to inflammation-associated tumorigenesis. Am J Pathol, 176, 952-67.
DOI
|
30 |
De Nitto D, Sarra M, Pallone F, et al (2010). Interleukin-21 triggers effector cell responses in the gut. World J Gastroenterol, 16, 3638-41.
DOI
|
31 |
Dill MT, Tornillo L, Fritzius T, et al (2013). Constitutive Notch2 signaling induces hepatic tumors in mice. Hepatology, 57, 1607-19.
DOI
|
32 |
Fre S, Pallavi SK, Huyghe M, et al (2009). Notch and Wnt signals cooperatively control cell proliferation and tumorigenesis in the intestine. Proc Natl Acad Sci U S A, 106, 6309-14.
DOI
|
33 |
Dontu G, Jackson KW, McNicholas E, et al (2004). Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells. Breast Cancer Res, 6, 605-15.
DOI
|
34 |
Fiala ES, Sohn OS, Hamilton SR (1987). Effects of chronic dietary ethanol on in vivo and in vitro metabolism of methylazoxymethanol and on methylazoxymethanolinduced DNA methylation in rat colon and liver. Cancer Res, 47, 5939-43.
|
35 |
Fina D, Sarra M, Fantini MC, et al (2008). Regulation of gut inflammation and th17 cell response by interleukin-21. Gastroenterology, 134, 1038-48.
DOI
|
36 |
Friedman RC, Farh KK, Burge CB, et al (2009). Most mammalian mRNAs are conserved targets of microRNAs. Genome Res, 19, 92-105.
|
37 |
Fujino S, Andoh A, Bamba S, et al (2003). Increased expression of interleukin 17 in inflammatory bowel disease. Gut, 52, 65-70.
DOI
ScienceOn
|
38 |
Chen Q, Wang H, Liu Y, et al (2012). Inducible microRNA-223 down-regulation promotes TLR-triggered IL-6 and IL-1beta production in macrophages by targeting STAT3. PLoS ONE, 7, 42971.
DOI
|
39 |
Carthew RW (2006). Gene regulation by microRNAs. Curr Opin Genet Dev, 16, 203-8.
DOI
ScienceOn
|
40 |
Catlett-Falcone R, Landowski TH, Oshiro MM, et al (1999). Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity, 10, 105-15.
DOI
ScienceOn
|
41 |
Corvinus FM, Orth C, Moriggl R, et al (2005). Persistent STAT3 activation in colon cancer is associated with enhanced cell proliferation and tumor growth. Neoplasia, 7, 545-55.
DOI
|
42 |
Dashwood RH, Suzui M, Nakagama H, et al (1998). High frequency of beta-catenin (ctnnb1) mutations in the colon tumors induced by two heterocyclic amines in the F344 rat. Cancer Res, 58, 1127-9.
|
43 |
Coussens LM, Werb Z (2002). Inflammation and cancer. Nature, 420, 860-7.
DOI
ScienceOn
|
44 |
Danese S, Mantovani A (2010). Inflammatory bowel disease and intestinal cancer: a paradigm of the Yin-Yang interplay between inflammation and cancer. Oncogene, 29, 3313-23.
DOI
ScienceOn
|
45 |
Darnell JE, Jr (2002). Transcription factors as targets for cancer therapy. Nat Rev Cancer, 2, 740-9.
DOI
ScienceOn
|
46 |
Baud V, Karin M (2009). Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls. Nat Rev Drug Discov, 8, 33-40.
DOI
ScienceOn
|
47 |
Becker C, Fantini MC, Schramm C, et al (2004). TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling. Immunity, 21, 491-501.
DOI
ScienceOn
|
48 |
Becker C, Fantini MC, Wirtz S, et al (2005). IL-6 signaling promotes tumor growth in colorectal cancer. Cell Cycle, 4, 217-20.
|
49 |
Bollrath J, Phesse TJ, von Burstin VA, et al (2009). gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis. Cancer Cell, 15, 91-102.
DOI
ScienceOn
|
50 |
Brand S (2009). Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease. Gut, 58, 1152-67.
DOI
ScienceOn
|
51 |
Bray SJ (2006). Notch signalling: a simple pathway becomes complex. Nat Rev Mol Cell Biol, 7, 678-89.
DOI
ScienceOn
|
52 |
Buettner R, Mora LB, Jove R (2002). Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. Clin Cancer Res, 8, 945-54.
|
53 |
Abraham C, Cho J (2009). Interleukin-23/Th17 pathways and inflammatory bowel disease. Inflamm Bowel Dis, 15, 1090-100.
DOI
ScienceOn
|
54 |
Aggarwal BB, Vijayalekshmi RV, Sung B (2009). Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe. Clin Cancer Res, 15, 425-30.
DOI
ScienceOn
|
55 |
Bromberg JF, Wrzeszczynska MH, Devgan G, et al (1999). Stat3 as an oncogene. Cell, 98, 295-303.
DOI
ScienceOn
|
56 |
Armanious H, Gelebart P, Mackey J, et al (2010). STAT3 upregulates the protein expression and transcriptional activity of beta-catenin in breast cancer. Int J Clin Exp Pathol, 3, 654-64.
|
57 |
Ivanov, II, McKenzie BS, Zhou L, et al (2006). The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell, 126, 1121-33.
DOI
ScienceOn
|
58 |
Jensen J, Pedersen EE, Galante P, et al (2000). Control of endodermal endocrine development by Hes-1. Nat Genet, 24, 36-44.
DOI
ScienceOn
|
59 |
Jin S, Mutvei AP, Chivukula IV, et al (2012). Non-canonical Notch signaling activates IL-6/JAK/STAT signaling in breast tumor cells and is controlled by p53 and IKKalpha/IKKbeta. Oncogene, 26, 517.
|
60 |
Ashokkumar P, Sudhandiran G (2008). Protective role of luteolin on the status of lipid peroxidation and antioxidant defense against azoxymethane-induced experimental colon carcinogenesis. Biomed Pharmacother, 62, 590-7.
DOI
ScienceOn
|
61 |
Bartel DP (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 116, 281-97.
DOI
ScienceOn
|
62 |
Ashokkumar P, Sudhandiran G (2011). Luteolin inhibits cell proliferation during Azoxymethane-induced experimental colon carcinogenesis via Wnt/ beta-catenin pathway. Invest New Drugs, 29, 273-84.
DOI
|
63 |
Atreya R, Mudter J, Finotto S, et al (2000). Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo. Nat Med, 6, 583-8.
DOI
ScienceOn
|
64 |
Atreya R, Neurath MF (2008). Signaling molecules: the pathogenic role of the IL-6/STAT-3 trans signaling pathway in intestinal inflammation and in colonic cancer. Curr Drug Targets, 9, 369-74.
DOI
ScienceOn
|
65 |
He TC, Sparks AB, Rago C, et al (1998). Identification of c-MYC as a target of the APC pathway. Science, 281, 1509-12.
DOI
ScienceOn
|
66 |
Grivennikov S, Karin M (2008). Autocrine IL-6 signaling: a key event in tumorigenesis? Cancer Cell, 13, 7-9.
DOI
ScienceOn
|
67 |
Harris TJ, Grosso JF, Yen HR, et al (2007). Cutting edge: An in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunity. J Immunol, 179, 4313-7.
DOI
|
68 |
He G, Karin M (2011). NF-kappaB and STAT3 - key players in liver inflammation and cancer. Cell Res, 21, 159-68.
DOI
ScienceOn
|
69 |
Heitzler P, Bourouis M, Ruel L, et al (1996). Genes of the Enhancer of split and achaete-scute complexes are required for a regulatory loop between Notch and Delta during lateral signalling in Drosophila. Development, 122, 161-71.
|
70 |
Hirahara K, Ghoreschi K, Laurence A, et al (2010). Signal transduction pathways and transcriptional regulation in Th17 cell differentiation. Cytokine Growth Factor Rev, 21, 425-34.
DOI
ScienceOn
|
71 |
Hyun YS, Han DS, Lee AR, et al (2012). Role of IL-17A in the development of colitis-associated cancer. Carcinogenesis, 33, 931-6.
DOI
ScienceOn
|
72 |
Iliopoulos D, Jaeger SA, Hirsch HA, et al (2010). STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer. Mol Cell, 39, 493-506.
DOI
ScienceOn
|
73 |
Itzkowitz SH, Yio X (2004). Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol, 287, 7-17.
DOI
ScienceOn
|
74 |
Kobayashi T, Okamoto S, Hisamatsu T, et al (2008). IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease. Gut, 57, 1682-9.
DOI
ScienceOn
|
75 |
Korinek V, Barker N, Morin PJ, et al (1997). Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science, 275, 1784-7.
DOI
ScienceOn
|
76 |
Korn T, Bettelli E, Oukka M, et al (2009). IL-17 and Th17 Cells. Annu Rev Immunol, 27, 485-517.
DOI
ScienceOn
|
77 |
Kozomara A, Griffiths-Jones S (2011). miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res, 39, 30.
DOI
ScienceOn
|
78 |
Kundu JK, Surh YJ (2008). Inflammation: gearing the journey to cancer. Mutat Res, 659, 15-30.
DOI
ScienceOn
|
79 |
Kusaba T, Nakayama T, Yamazumi K, et al (2005). Expression of p-STAT3 in human colorectal adenocarcinoma and adenoma; correlation with clinicopathological factors. J Clin Pathol, 58, 833-8.
DOI
ScienceOn
|
80 |
Garg P, Sarma D, Jeppsson S, et al (2010). Matrix metalloproteinase-9 functions as a tumor suppressor in colitis-associated cancer. Cancer Res, 70, 792-801.
DOI
ScienceOn
|
81 |
Genta RM (2003). The gastritis connection: prevention and early detection of gastric neoplasms. J Clin Gastroenterol, 36, 61-2.
DOI
ScienceOn
|
82 |
Gregorieff A, Clevers H (2005). Wnt signaling in the intestinal epithelium: from endoderm to cancer. Genes Dev, 19, 877-90.
DOI
ScienceOn
|
83 |
Grivennikov S, Karin E, Terzic J, et al (2009). IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell, 15, 103-13.
DOI
ScienceOn
|
84 |
Karin M, Greten FR (2005). NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol, 5, 749-759.
DOI
ScienceOn
|
85 |
Jump RL, Levine AD (2004). Mechanisms of natural tolerance in the intestine: implications for inflammatory bowel disease. Inflamm Bowel Dis, 10, 462-78.
DOI
ScienceOn
|
86 |
Kanai T, Nemoto Y, Kamada N, et al (2009). Homeostatic (IL-7) and effector (IL-17) cytokines as distinct but complementary target for an optimal therapeutic strategy in inflammatory bowel disease. Curr Opin Gastroenterol, 25, 306-13.
DOI
ScienceOn
|
87 |
Kargl J, Haybaeck J, Stancic A, et al (2013). O-1602, an atypical cannabinoid, inhibits tumor growth in colitis-associated colon cancer through multiple mechanisms. J Mol Med, 91, 449-58.
DOI
|
88 |
Kathiria AS, Neumann WL, Rhees J, et al (2012). Prohibitin attenuates colitis-associated tumorigenesis in mice by modulating p53 and STAT3 apoptotic responses. Cancer Res, 72, 5778-89.
DOI
|
89 |
Kawada M, Seno H, Uenoyama Y, Set al (2006). Signal transducers and activators of transcription 3 activation is involved in nuclear accumulation of beta-catenin in colorectal cancer. Cancer Res, 66, 2913-7.
DOI
ScienceOn
|
90 |
Kaur M, Velmurugan B, Tyagi A, et al (2010). Silibinin suppresses growth of human colorectal carcinoma SW480 cells in culture and xenograft through down-regulation of beta-catenin-dependent signaling. Neoplasia, 12, 415-24.
DOI
|
91 |
Kawanishi S, Hiraku Y, Pinlaor S, et al (2006). Oxidative and nitrative DNA damage in animals and patients with inflammatory diseases in relation to inflammation-related carcinogenesis. Biol Chem, 387, 365-72.
|
92 |
Kim JH, Kim JE, Liu HY, et al (2008). Regulation of interleukin-6-induced hepatic insulin resistance by mammalian target of rapamycin through the STAT3-SOCS3 pathway. J Biol Chem, 283, 708-15.
DOI
ScienceOn
|
93 |
McKay CJ, Glen P, McMillan DC (2008). Chronic inflammation and pancreatic cancer. Best Pract Res Clin Gastroenterol, 22, 65-73.
DOI
ScienceOn
|
94 |
Mantovani A, Allavena P, Sica A, et al (2008). Cancer-related inflammation. Nature, 454, 436-44.
DOI
ScienceOn
|
95 |
Maynard CL, Weaver CT (2009). Intestinal effector T cells in health and disease. Immunity, 31, 389-400.
DOI
ScienceOn
|
96 |
McGeachy MJ, Cua DJ (2008). Th17 cell differentiation: the long and winding road. Immunity, 28, 445-53.
DOI
ScienceOn
|
97 |
Mitsuyama K, Toyonaga A, Sasaki E, et al (1995). Soluble interleukin-6 receptors in inflammatory bowel disease: relation to circulating interleukin-6. Gut, 36, 45-9.
DOI
|
98 |
Neuman MG (2007). Immune dysfunction in inflammatory bowel disease. Transl Res, 149, 173-86.
DOI
ScienceOn
|
99 |
Monteleone G, Monteleone I, Fina D, et al (2005). Interleukin-21 enhances T-helper cell type I signaling and interferongamma production in Crohn's disease. Gastroenterology, 128, 687-94.
DOI
ScienceOn
|
100 |
Mudter J, Neurath MF (2007). IL-6 signaling in inflammatory bowel disease: pathophysiological role and clinical relevance. Inflamm Bowel Dis, 13, 1016-23.
DOI
ScienceOn
|
101 |
Oberg AL, French AJ, Sarver AL, et al (2011). miRNA expression in colon polyps provides evidence for a multihit model of colon cancer. PLoS ONE, 6, 620465.
|
102 |
Johnson GE, Ivanov VN, Hei TK (2008). Radiosensitization of melanoma cells through combined inhibition of protein regulators of cell survival. Apoptosis, 13, 790-802.
DOI
ScienceOn
|
103 |
Lakatos PL, Lakatos L (2008). Risk for colorectal cancer in ulcerative colitis: changes, causes and management strategies. World J Gastroenterol, 14, 3937-47.
DOI
ScienceOn
|
104 |
Scheid MP, Woodgett JR (2003). Unravelling the activation mechanisms of protein kinase B/Akt. FEBS Lett, 546, 108-12.
DOI
ScienceOn
|
105 |
Scheller J, Ohnesorge N, Rose-John S (2006). Interleukin-6 trans-signalling in chronic inflammation and cancer. Scand J Immunol, 63, 321-9.
DOI
ScienceOn
|
106 |
Kusaba T, Nakayama T, Yamazumi K, et al (2006). Activation of STAT3 is a marker of poor prognosis in human colorectal cancer. Oncol Rep, 15, 1445-51.
|
107 |
Lassmann S, Schuster I, Walch A, et al (2007). STAT3 mRNA and protein expression in colorectal cancer: effects on STAT3-inducible targets linked to cell survival and proliferation. J Clin Pathol, 60, 173-9.
|
108 |
Lin L, Deangelis S, Foust E, et al (2010). A novel small molecule inhibits STAT3 phosphorylation and DNA binding activity and exhibits potent growth suppressive activity in human cancer cells. Mol Cancer, 9, 217.
DOI
ScienceOn
|
109 |
Lee H, Herrmann A, Deng JH, et al (2009). Persistently activated Stat3 maintains constitutive NF-kappaB activity in tumors. Cancer Cell, 15, 283-93.
DOI
ScienceOn
|
110 |
Lima RT, Busacca S, Almeida GM, et al (2011). MicroRNA regulation of core apoptosis pathways in cancer. Eur J Cancer, 47, 163-74.
DOI
ScienceOn
|
111 |
Lin L, Fuchs J, Li C, et al (2011). STAT3 signaling pathway is necessary for cell survival and tumorsphere forming capacity in ALDH(+)/CD133(+) stem cell-like human colon cancer cells. Biochem Biophys Res Commun, 416, 246-51.
DOI
ScienceOn
|
112 |
Lu T, Stark GR (2004). Cytokine overexpression and constitutive NFkappaB in cancer. Cell Cycle, 3, 1114-7.
|
113 |
Riemenschneider MJ, Betensky RA, Pasedag SM, et al (2006). AKT activation in human glioblastomas enhances proliferation via TSC2 and S6 kinase signaling. Cancer Res, 66, 5618-23.
DOI
ScienceOn
|
114 |
Pikarsky E, Porat RM, Stein I, et al (2004). NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature, 431, 461-6.
DOI
ScienceOn
|
115 |
Reddy BS (2004). Studies with the azoxymethane-rat preclinical model for assessing colon tumor development and chemoprevention. Environ Mol Mutagen, 44, 26-35.
DOI
ScienceOn
|
116 |
Reedijk M, Odorcic S, Zhang H, et al (2008). Activation of Notch signaling in human colon adenocarcinoma. Int J Oncol, 33, 1223-9.
|
117 |
Robertson GP (2005). Functional and therapeutic significance of Akt deregulation in malignant melanoma. Cancer Metastasis Rev, 24, 273-85.
DOI
ScienceOn
|
118 |
Sakamoto K, Maeda S, Hikiba Y, et al (2009). Constitutive NF-kappaB activation in colorectal carcinoma plays a key role in angiogenesis, promoting tumor growth. Clin Cancer Res, 15, 2248-58.
DOI
ScienceOn
|
119 |
Rose-John S, Mitsuyama K, Matsumoto S, et al (2009). Interleukin-6 trans-signaling and colonic cancer associated with inflammatory bowel disease. Curr Pharm Des, 15, 2095-103.
DOI
ScienceOn
|
120 |
Rubie C, Frick VO, Pfeil S, et al (2007). Correlation of IL-8 with induction, progression and metastatic potential of colorectal cancer. World J Gastroenterol, 13, 4996-5002.
|
121 |
Sartor RB (2006). Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol, 3, 390-407.
DOI
ScienceOn
|
122 |
Sarver AL, French AJ, Borralho PM, et al (2009). Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states. BMC Cancer, 9, 401.
DOI
ScienceOn
|
123 |
Takahashi M, Fukuda K, Sugimura T, et al (1998). Beta-catenin is frequently mutated and demonstrates altered cellular location in azoxymethane-induced rat colon tumors. Cancer Res, 58, 42-6.
|
124 |
Tenesa A, Dunlop MG (2009). New insights into the aetiology of colorectal cancer from genome-wide association studies. Nat Rev Genet, 10, 353-8.
|
125 |
Tetsu O, McCormick F (1999). Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature, 398, 422-6.
DOI
ScienceOn
|
126 |
Schroeter EH, Kisslinger JA, Kopan Rn (1998). Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain. Nature, 393, 382-6.
DOI
ScienceOn
|
127 |
Pandurangan AK, Dharmalingam P, Ananda Sadagopan SK, et al (2012). Effect of luteolin on the levels of glycoproteins during azoxymethane-induced colon carcinogenesis in mice. Asian Pac J Cancer Prev, 13, 1569-73.
과학기술학회마을
DOI
ScienceOn
|
128 |
Okayasu I, Ohkusa T, Kajiura K, et al (1996). Promotion of colorectal neoplasia in experimental murine ulcerative colitis. Gut, 39, 87-92.
DOI
ScienceOn
|
129 |
Pandurangan AK (2013). Potential Targets for Prevention of Colorectal Cancer: a Focus on PI3K/Akt/mTOR and Wnt Pathways. Asian Pac J Cancer Prev, 14, 2201-5.
과학기술학회마을
DOI
ScienceOn
|
130 |
Pandurangan AK, Ananda Sadagopan SK, Dharmalingam P et al (2013). Luteolin, a bioflavonoid inhibits Azoxymethaneinduced colorectal cancer through Nrf2 signaling. Toxicol Mech Methods, 24, 13-20.
|
131 |
Petroulakis E, Mamane Y, Le Bacquer O,et al (2006). mTOR signaling: implications for cancer and anticancer therapy. Br J Cancer, 94, 195-9.
DOI
ScienceOn
|
132 |
Sohn OS, Ishizaki H, Yang CS, et al (1991). Metabolism of azoxymethane, methylazoxymethanol and N-nitrosodimethylamine by cytochrome P450IIE1. Carcinogenesis, 12, 127-31.
DOI
ScienceOn
|
133 |
Shafie NH, Mohd Esa N, Ithnin H, et al (2013). Prophylactic Inositol Hexaphosphate (IP6) inhibits colon cancer through involvement of Wnt/-catenin and COX-2 pathway. BioMed Res Int, 2013, 681027.
|
134 |
Shanmugam MK, Rajendran P, Li F, et al (2011). Ursolic acid inhibits multiple cell survival pathways leading to suppression of growth of prostate cancer xenograft in nude mice. J Mol Med, 89, 713-27.
DOI
ScienceOn
|
135 |
Korn T, Oukka M, Kuchroo V, et al (2007). Th17 cells: effector T cells with inflammatory properties. Semin Immunol, 19, 362-71.
DOI
ScienceOn
|
136 |
Caprioli F, Sarra M, Caruso R, et al (2008). Autocrine regulation of IL-21 production in human T lymphocytes. J Immunol, 180, 1800-7.
DOI
|
137 |
Bernstein CN, Blanchard JF, Kliewer E, et al (2001). Cancer risk in patients with inflammatory bowel disease: a populationbased study. Cancer, 91, 854-62.
DOI
|
138 |
Heikkila K, Ebrahim S, Lawlor DA (2008). Systematic review of the association between circulating interleukin-6 (IL-6) and cancer. Eur J Cancer, 44, 937-945.
DOI
ScienceOn
|
139 |
Ogura H, Murakami M, Okuyama Y, et al (2008). Interleukin-17 promotes autoimmunity by triggering a positive-feedback loop via interleukin-6 induction. Immunity, 29, 628-36.
DOI
ScienceOn
|
140 |
Schottelius AJ, Dinter H (2006). Cytokines, NF-kappaB, microenvironment, intestinal inflammation and cancer. Cancer Treat Res, 130, 67-87.
DOI
|